Two-Part Dose-Confirming Study of Pulsed Inhaled Nitric Oxide in Subjects With WHO Group 3 Pulmonary Hypertension Associated With COPD

NCT01728220 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

159

Enrollment

INDUSTRY

Sponsor class

Conditions

Pulmonary Hypertension
Chronic Obstructive Pulmonary Disease

Interventions

COMBINATION_PRODUCT: Inhaled NO delivered via INOpulse DS-C Device
COMBINATION_PRODUCT: Placebo delivered via INOpulse DS-C Device

Sponsor

Bellerophon Pulse Technologies